In 2022, New Pharma CEE, UAB had revenue of 243.8 thousand EUR.
Warning
Incomplete reports
Lithuanian financial data is sourced from Registrų Centras open data. Banks and financial institutions report to the Bank of Lithuania and may have limited or no data in this registry.
Last available data: 2022
| year | 2022Latest | 2021 | 2020 |
|---|---|---|---|
Revenue | 243,8k € | 0 € -100.0% | 119,4k € |
Profit | - | - | - |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - | - -100.0% |
Employees | - | - | - |
Overall rating | C+62/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 70/100 |
Business activity | 60/100 |
| Overall risk | Medium |
Incomplete reports | |
Possible tax debts | |
No financial data available | |
Incomplete reports | |
| Description | Registered |
|---|---|
| CEO (Male) |
New Pharma CEE, UAB is located at Vilnius, Perkūnkiemio g. 4A, LT-12128, LT-LT-12128.
The shareholders of New Pharma CEE, UAB include 1 Lithuanian legal entities. View ownership details →
Yes, New Pharma CEE, UAB is registered as an active VAT payer with VAT number LT100004850315.
New Pharma CEE, UAB was founded on May 21, 2009. The company has been operating for 17 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 17 years | - | 0% | |
Net revenue | 243 750,00 € | - | 0% | |
Registered capital | 95 431,00 € | - | 0% |
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Annual financial report for 2018.
Annual financial report for 2016.
Registered in the Lithuanian register of legal entities.